I. Shaw

发表

THE NEW ZEALAND MEDICAL JOURNAL

S. Gaw, M. Stringer, I. Shaw, 2004 .

Dietary exposure to xenoestrogens in New Zealand.

P. Cressey, I. Shaw, B. Thomson, 2003, Journal of environmental monitoring : JEM.

The effect of Saccharomyces cerevisiae on the stability of the herbicide glyphosate during bread leavening

I. Shaw, F. L. Low, J. Gerrard, 2005, Letters in applied microbiology.

A method to determine residue levels of persistent organochlorine pesticides in human milk from Indonesian women.

I. Shaw, E. Burke, A. J. Holden, 2003, Chemosphere.

Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)

Andrew P Jones, A. Jones, I. Shaw, 1995, Journal of the Neurological Sciences.

MICROBIOLOGICAL SAFETY OF MEAT | Prions and Viruses

I. Shaw, 2004 .

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

R. Souhami, R. Souhami, A. Mclean, 2004, Cancer Chemotherapy and Pharmacology.

Bioactive isoflavones in functional foods: the importance of gut microflora on bioavailability.

I. Shaw, Nicola J. Turner, B. Thomson, 2003, Nutrition reviews.

Does exposure to thyroxine-mimics cause feline thyroid hyperplasia?

I. Shaw, K. Hill, 2014, Veterinary Record.

Metabolism and excretion of the liver-protective agent (+)-catechin in experimental hepatitis.

I. Shaw, L. Griffiths, A. Hackett, 1982, Xenobiotica; the fate of foreign compounds in biological systems.

Identification of the major biliary metabolite of (+)-catechin in the rat.

I. Shaw, L. Griffiths, 1980, Xenobiotica; the fate of foreign compounds in biological systems.

Intimate estrogen receptor-α/ligand relationships signal biological activity.

I. Shaw, Hui Ye, Samantha Z. Dudley, 2018, Toxicology.

Does the oestrogen receptor encourage oestrogenicity in environmental pollutants? The case of 4-nonylphenol

L. A. Graham, I. Shaw, I. Shaw, 2011, SAR and QSAR in environmental research.

The effect of dietary endocrine disruptors on the developing fetus.

M. Mitchell, B. Balakrishnan, I. Shaw, 2009 .

Is there a link between dietary phytoestrogens and reproductive health in men? A meta‐analysis of data from the USA and China

I. Shaw, David Lim, 2016 .

Xenoestrogens: The Ultimate Biochemical Feminists

L. A. Graham, I. Shaw, 2009 .

Alteration of superoxide dismutase activity in the anterior horn in motoneuron disease patients

P. Fitzmaurice, I. Shaw, J. Mitchell, 1995, Journal of the Neurological Sciences.

Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis.

P. Fitzmaurice, I. Shaw, J. Mitchell, 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

CNS distribution of free‐radical inactivating enzymes in amyotrophic lateral sclerosis

P. Fitzmaurice, I. Shaw, J. Mitchell, 1996, Annals of neurology.

Evidence for DNA damage in amyotrophic lateral sclerosis.

H. Kleiner, T. Monks, S. Lau, 1996, Muscle & nerve.

Estrogenicity of pyrethroid insecticide metabolites.

A. Abell, I. Shaw, A. Mccarthy, 2006, Journal of environmental monitoring : JEM.

Food flavonoid ligand structure/estrogen receptor-α affinity relationships - toxicity or food functionality?

I. Shaw, Hui Ye, 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Identification of brain metabolites by magnetic resonance spectroscopy in MND/ALS

J. P. Redmond, A. Jones, I. Shaw, 1996, Journal of the Neurological Sciences.

Cu/Zn superoxide dismutase free radicals, and motoneuron disease

T. Phillips, J. Whittington, I. Shaw, 1993, The Lancet.

Mesna--a short review.

I. Shaw, M. I. Graham, 1987, Cancer treatment reviews.

A review of the potential impact of dietary endocrine disrupters on the consumer

I. Shaw, S. McCully, 2002 .

Detection of the c-myc oncogene product in testicular cancer.

I. Shaw, 1985, British Journal of Cancer.

Dietary isoflavone-induced, estrogen receptor-β-mediated proliferation of Caco-2 cells is modulated by gallic acid.

I. Shaw, Hui Ye, 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

The changing science of glyphosate

I. Shaw, 2022 .

Heavy metals in seafood - what is the risk to the consumer?

I. Shaw, 2013 .

Escherichia coli biotransformation of daidzein fermentation products from soy‐based foods—relevance to food oestrogenicity‐based functionality

I. Shaw, Hui Ye, Samantha Z. Dudley, 2017 .

Thermal stability of organophosphorus pesticide triazophos and its relevance in the assessment of risk to the consumer of triazophos residues in food.

L. Chen, I. Shaw, A. J. Holden, 2001, Journal of agricultural and food chemistry.

Analysis of D-penicillamine by high-performance liquid chromatography with glassy carbon electrochemical detection.

A. Mclean, I. Shaw, C. H. Boult, 1983, Journal of chromatography.

Chemical residues, food additives and natural toxicants in food – the cocktail effect

I. Shaw, Ian C. Shaw, 2014 .

New Zealand Malayan war veterans' exposure to dibutylphthalate is associated with an increased incidence of cryptorchidism, hypospadias and breast cancer in their children.

I. Shaw, Matthew Carran, 2012, The New Zealand medical journal.

2-Chloroacetaldehyde, a metabolite of cyclophosphamide in the rat.

A. Mclean, I. Shaw, M. I. Graham, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

A mass spectral study of cyclophosphamide with special reference to differences in isomeric structures

I. Shaw, M. Mruzek, 1984 .

Polystyrene as Hazardous Household Waste

I. Shaw, T. Farrelly, 2017 .

Species differences in the metabolism and toxicity of agrochemicals and veterinary medicines.

I. Shaw, 1990 .

ENCEPHALOPATHY ASSOCIATED WITH IFOSPHAMIDE/MESNA THERAPY

D. Blake, G. Blackledge, I. Shaw, 1985, The Lancet.

2-Chloroacetaldehyde: a metabolite of cyclophosphamide in the rat.

A. Mclean, I. Shaw, M. I. Graham, 1983, Cancer treatment reviews.

Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.

I. Shaw, M. S. Jones, R. Murrell, 1985, European journal of cancer & clinical oncology.

Mesna and oxazaphosphorine cancer chemotherapy.

I. Shaw, 1987, Cancer treatment reviews.

The metabolism and excretion of [14C]imipramine in an experimental hepatitis.

I. Shaw, L. Griffiths, A. Hackett, 1984, Xenobiotica; the fate of foreign compounds in biological systems.

Safe to eat.

I. Shaw, 1995, Environmental health perspectives.

Should We Legalise Recreational Drugs? An Ethical Question for Animals and Humans

I. Shaw, 2013, Pharmaceutical Medicine.

Mechanisms of non-genotoxic carcinogenesis.

I. Shaw, H. B. Jones, Ian C. Shaw, 1994, Trends in pharmacological sciences.

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease.

J. Rucklidge, I. Shaw, Gina M Broom, 2019, Nutrition.

HanaaAchram A thesis submitted as partial fulfilment of the requirements for the degree of Master of Science at the University of Otago, Dunedin, New Zealand Presented for marking March 2014

I. Shaw, Allison M. Miller, A. Pilbrow, 2022 .

Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side-chain from liver, kidney and muscle tissues from pigs.

L. Hoogenboom, I. Shaw, R. Parker, 1992, Food additives and contaminants.

Levamisole toxicity in fibre goats

I. Shaw, F. Jackson, G. Cawley, 1993, Veterinary Record.

Are over-the-counter fish oil supplements safe, effective and accurate with labelling? Analysis of 10 New Zealand fish oil supplements.

J. Rucklidge, I. Shaw, 2020, The New Zealand medical journal.

Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline.

T. Phillips, I. Shaw, J. Mitchell, 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

Motor neurone disease - a methyl bromide exposure cluster points to a causal mechanism

I. Shaw, 2010, Human & experimental toxicology.

Do Molecular Structures of Migraine Drugs Point to a Common Cause of this Elusive Disease and Suggest Future Drug Designs?

I. Shaw, Mark J. Brinsden, 2015, Pharmaceutical Medicine.

Determination of sodium 2-mercaptoethanesulphonate by high-performance liquid chromatography using post-column reaction colorimetry or electrochemical detection.

I. Shaw, B. Sidau, 1984, Journal of chromatography.

Enzymic digestion of liver tissue to release barbiturates, salicylic acid and other acidic compounds in cases of human poisoning.

I. Shaw, M. D. Osselton, H. M. Stevens, 1978, The Analyst.

In Vitro Studies on the Metabolism of Antipyrine in the Pig and Rat: with Special Refierence to Veterinary Medicine Licensing

I. Shaw, Luis A. Sainz-Pardo Clares, 1993, Human and Experimental Toxicology.

The use of in vitro methods for studying drug metabolism to replace animal studies as part of veterinary medicines product licence applications.

I. Shaw, 1994, Toxicology in vitro : an international journal published in association with BIBRA.

Ranking the risk of pesticide dietary intake.

Juliet A Gerrard, P. Cressey, J. Gerrard, 2004, Pest management science.

The prevention by (+)-Cyanidanol-3 of hepatitis-induced changes in the disposition of imipramine in the rat.

I. Shaw, L. Griffiths, A. Hackett, 1984, Biochemical Pharmacology.

Excretion of cyclophosphamide metabolites in bile.

I. Shaw, M. I. Graham, Ian C. Shaw, 1984, Biochemical pharmacology.

3′-O-Methyl-(+)-catechin glucuronide and 3′-O-methyl-(+)-catechin sulphate: new urinary metabolites of (+)-catechin in the rat and the marmoset

I. Shaw, L. Griffiths, A. Hackett, 1982, Experientia.

INFUSION OF IFOSPHAMIDE PLUS MESNA

I. Shaw, J. Rose, 1984, The Lancet.

Are the amounts of vitamins in commercially available dietary supplement formulations relevant for the management of psychiatric disorders in children?

J. Rucklidge, I. Shaw, A. L. Harris, 2014, The New Zealand medical journal.

Endocrine-disrupting chemicals in food

I. Shaw, 2009 .

A Possible Biological Mechanism for the B Vitamins Altering Behaviour in Attention-Deficit/Hyperactivity Disorder

J. Rucklidge, I. Shaw, R. Hughes, 2010, Pharmaceutical Medicine.